We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MTN:JSEMTN Group Limited Analysis

Data as of 2026-07-03 - not real-time

ZAC 22,557.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

MTN’s share price of ZAc 22,557 sits just above its 20‑day SMA of 22,270 and comfortably over the 50‑day SMA of 21,495, confirming the current bullish trend indicated by the technical screen. The 14‑day RSI of 57 reinforces a neutral‑to‑bullish momentum without showing overbought stress. Although the MACD histogram is negative (‑37) and the signal line is higher than the MACD line, the overall trend remains upward, and the increasing volume trend adds confirmation. The stock’s beta of roughly 0.1 (computed) signals very low price sensitivity to market swings, while 30‑day volatility of 25.5% suggests moderate price swings. Fundamentally, MTN delivers a 20.5% revenue growth year‑over‑year, a robust gross margin of 68% and operating margin of 30%, delivering healthy cash conversion with free cash flow of ZAc 45 bn. The DCF‑derived fair value of ZAc 69,478 implies an upside of roughly 48% versus the current price, classifying the equity as significantly undervalued. Dividend sustainability looks solid, with a 2.22% yield, a modest payout ratio of 31% and ample operating cash flow to cover the dividend.
Recent analyst commentary notes a modest downward revision to the fair‑value estimate, but the cut is small relative to the large valuation gap, keeping the stock attractive. The balance sheet shows a high debt‑to‑equity of 87.5, yet the company’s strong operating cash flow and sizable cash reserves mitigate immediate refinancing concerns. Geographic exposure across 20+ African markets and the MENA region adds growth upside but also introduces political and currency headwinds. Regulatory risk is moderate, as telecom licences in these jurisdictions are tightly controlled, but MTN’s long‑standing presence and diversified service portfolio provide a buffer. With a forward P/E of 10.2 versus an industry average of 16.7, earnings are expected to accelerate, supporting the “growth” classification in the valuation mix. Given the confluence of technical strength, sizable upside, solid dividend and resilient cash generation, the stock is positioned for outperformance in the near‑to‑mid term. Investors should monitor debt levels and any macro‑political developments, but the current risk‑adjusted profile remains favorable.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price above short‑term moving averages
  • Increasing volume confirming bullish momentum
  • RSI in comfortable range

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervaluation with ~48% upside
  • Strong free cash flow supporting dividend
  • Forward P/E compression vs peers

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Exposure to emerging‑market regulatory and currency risks
  • High debt level requiring careful monitoring
  • Sustainable dividend and resilient earnings

Key Metrics & Analysis

Financial Health

Revenue Growth20.50%
Profit Margin8.94%
P/E Ratio20.5
ROE17.83%
ROA9.56%
Debt/Equity87.54
P/B Ratio2.9
Op. Cash FlowZAC77.9B
Free Cash FlowZAC45.0B
Industry P/E16.7

Technical Analysis

TrendBullish
RSI57.1
SupportZAC 20,748.00
ResistanceZAC 23,286.00
MA 20ZAC 22,270.05
MA 50ZAC 21,494.96
MA 200ZAC 18,469.78
MACDBearish
VolumeIncreasing
Fear & Greed Index92.59

Valuation

Fair ValueZAC 69,477.52
Target PriceZAC 22,666.67
Upside/Downside0.49%
GradeUndervalued
TypeGrowth
Dividend Yield2.22%

Risk Assessment

Beta0.10
Volatility25.52%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.